Evofem Biosciences (EVFM) Cash from Financing Activities (2014 - 2026)
Evofem Biosciences (EVFM) recorded Cash from Financing Activities of $1.05 million in Q2 2026, down 59.1% from $2.56 million a year earlier.
Powered by 
Analysis
Evofem Biosciences (EVFM) Cash from Financing Activities (2014 - 2026) Analysis & Trends
On a TTM basis, Evofem Biosciences' Cash from Financing Activities came in at $14,000 as of Jun 30, 2026, down 99.8% year-over-year; for FY2025, it came in at $1.89 million, down 59.0% from FY2024.
- Annual Cash from Financing Activities has declined for five straight years, with a five-year compound annual growth rate of -58.5% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $4.62 million in FY2024 (-3.4%), $4.78 million in FY2023 (-92.3%), $61.94 million in FY2022 (-31.7%) and $90.69 million in FY2021 (-41.2%).
- Quarterly Cash from Financing Activities has ranged from -$498,000 in Q1 2026 to $41.36 million in Q2 2022 over the past five years.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 627.4% in Q4 2024, against a decline of 98.6% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$498,000 (Q1 2026), -$290,000 (Q4 2025) and -$244,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 1.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | -498,000.00 |
| Dec 31, 2025 | -290,000.00 |
| Sep 30, 2025 | -244,000.00 |
| Jun 30, 2025 | 2.56 Mn |
| Mar 31, 2025 | -135,000.00 |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 998,000.00 |
| Dec 31, 2023 | 340,000.00 |
| Sep 30, 2023 | 2.14 Mn |
| Jun 30, 2023 | 597,000.00 |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 41.36 Mn |
| Mar 31, 2022 | 15.13 Mn |
| Dec 31, 2021 | 9.87 Mn |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 52.81 Mn |
| Mar 31, 2021 | 28.01 Mn |
API Access
Evofem Biosciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();